Filip Janku, Chief Medical Officer at Monte Rosa Therapeutics, Inc. (GLUE), sold 41,845 shares at $20.22 ($882K) on 2026-06-23, disclosed to the SEC on 2026-06-25.
Scheduled sale ($882k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.22 | 11,845 | $240K | 27.2% |
| 2 | $21.42 | 30,000 | $643K | 72.8% |
| Total | $21.08 avg | 41,845 | $882K | 100% |
| Filing → |
| GLUE | SELL | 2026-02-24 | $179K | — | Filing → |
| GLUE | SELL | 2026-01-05 | $48K | — | Filing → |